Calton & Associates, Inc. Astrazeneca PLC Transaction History

Calton & Associates, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 25, 2019	SELL	$35.49 - $43.02 $242,964 - $294,514	-6,846 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$36.86 - $41.49 $32,731 - $36,843	-888 Reduced 11.48%	6,846 $260,000
Q3 2018 Oct 24, 2018	BUY	$34.76 - $39.72 $15,016 - $17,159	432 Added 5.92%	7,734 $306,000
Q2 2018 Aug 10, 2018	BUY	$34.55 - $37.05 $252,284 - $270,539	7,302 New	7,302 $287,000
Q1 2018 Apr 17, 2018	SELL	$32.97 - $36.63 $165,674 - $184,065	-5,025 Closed	0 $0
Q4 2017 Feb 05, 2018	BUY	$32.09 - $34.78 $161,252 - $174,769	5,025	5,025 $181,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.